Delek US director receives 3,436-share stock grant
Schwartzstein Christine Benson reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Schwartzstein Christine Benson reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Christine Benson Schwartzstein received a grant of 3,436 shares of common stock on June 10, 2026, valued at $48.01 per share. This was an equity award rather than an open-market purchase. After the grant, she directly owns 18,613 shares of Delek US common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,436 | $48.01 | $165K |
Key Figures
Key Terms
Form 4 regulatory
Common Stock financial
Grant, award, or other acquisition financial
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Delek US (DK) report for Christine Benson Schwartzstein?
Was the Delek US (DK) insider transaction a stock purchase or a grant?
What is the significance of the $48.01 price on the Delek US (DK) Form 4?
Does the Delek US (DK) Form 4 show any stock sales by Christine Benson Schwartzstein?
AI-generated analysis. How Rhea-AI works. Not financial advice.